Ann Mullally
VA Palo Alto Health Care System(US)Stanford Medicine(US)Stanford University(US)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Eosinophilic Disorders and Syndromes, Kruppel-like factors research
Most-Cited Works
- → Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies(2009)716 cited
- → Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms(2018)439 cited
- → TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis(2009)418 cited
- → Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells(2010)395 cited
- → Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells(2010)387 cited
- → Physiologic Expression of Sf3b1 K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation(2016)384 cited